Growing community of inventors

Leuven, Belgium

Dirk Jochmans

Average Co-Inventor Count = 5.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Dirk JochmansJohan Neyts (2 patents)Dirk JochmansKatherine L Radtke (2 patents)Dirk JochmansHannah Peters (2 patents)Dirk JochmansEric J Snijder (2 patents)Dirk JochmansJohan Neyts (0 patent)Dirk JochmansHannah L Peters (0 patent)Dirk JochmansKatherine L Radtke (0 patent)Dirk JochmansEric J Snijder (0 patent)Dirk JochmansHannah L Peters (0 patent)Dirk JochmansDirk Jochmans (2 patents)Johan NeytsJohan Neyts (12 patents)Katherine L RadtkeKatherine L Radtke (8 patents)Hannah PetersHannah Peters (2 patents)Eric J SnijderEric J Snijder (2 patents)Johan NeytsJohan Neyts (0 patent)Hannah L PetersHannah L Peters (0 patent)Katherine L RadtkeKatherine L Radtke (0 patent)Eric J SnijderEric J Snijder (0 patent)Hannah L PetersHannah L Peters (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University System of Maryland (2 from 1,926 patents)

2. Katholieke Universiteit Leuven (1 from 345 patents)

3. Leiden University Medical Center (1 from 15 patents)

4. Katholieke Universiteit Leuven/lieden University Medical Center, Rc Leiden (1 from 1 patent)


2 patents:

1. 10226434 - Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity

2. 10058516 - Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…